Our experience suggests that physician-modified thoracic stent-grafts are feasible for aortic arch lesions and provide encouraging results in the short term. Durability concerns will need to be assessed.

No abstract

Background: The aim of this study was to investigate the influence of dialysis on midterm results after treatment of aortic diseases. Methods: Between May 2007 and April 2013, 20 consecutive patients underwent endovascular aortic repair (n=14) and graft replacement (n=6). Of them, 7 patients required emergency procedures due to rupture (n=5) or acute type A aortic dissection (n=2). Results: There were four early deaths. Survival rates at 1 and 3 years were 64% ± 11% and 43% ± 12%, respectively. One patient died of adverse aorta-related events. Freedom from late aortic events at 1, 2, and 3 years were 46% ± 13%, 30% ± 14%, and 20% ± 12%, respectively. Late aortic events (n=9) included six new diseases and two endoleaks. Conclusions: Late aortic events occurred in nearly half of dialysis patients undergoing aortic repair. Thus close follow-up surveillance is needed.

No abstract

and 29% vs 72% at 6 months. The primary patency rates of stent graft vs balloon groups at 3 months, 6 months, and 12 months were 91.7%, 83.2%, and 46.9% vs 65.3%, 27.8%, and 7.8%. The mean primary patency after treatment was 380.22 6 28.54 days for the stent graft group and 151.08 6 16.79 days for balloon group.Conclusions: Stent graft provides a better solution over plain balloon angioplasty on hemodialysis graft outlet stenosis treatment, with a lower postintervention restenosis rate and longer primary patency.